All three cholinesterase inhibitors work in a similar way, but one might be better for someone than another. For instance, a person may have fewer side effects from one. Eventually, the disease will ...

Dementia is a condition that affects memory, thinking, and the ability to perform everyday tasks. As it progresses, it can ...

Cholinesterase inhibitors prevent the breakdown ... chemical are low in the brains of people with AD. The use of these drugs can partially correct the deficit. The three ChEIs now available ...

Currently approved drugs for AD target cholinesterase, to reduce acetylcholine degradation, and N-methyl-D-aspartate (NMDA) receptors, to prevent excitotoxicity, but they have limited effects on ...

Lewy body disease (LBD), which includes dementia with Lewy bodies (DLB) and Parkinson’s disease with or without dementia, is ...

Cholinesterase inhibitors are a group of drugs that increase the availability of acetylcholine -- a chemical messenger that's important for memory and learning. The drugs are used to treat ...

Potentiates neuromuscular blockers (eg, succinylcholine), cholinesterase inhibitors, cholinergic agonists (eg, bethanechol). Antagonizes anticholinergics. Caution with drugs that slow heart rate.

Some of the most commonly used drugs in dementia are cholinesterase inhibitors, which prevent the breakdown of acetylcholine, a neurotransmitter involved in learning and memory. Common ...

This medication is a local anesthetic used to ... (Contraindications) Hypersensitivity, complete heart block, low plasma-cholinesterase concentrations, pyrogenic infection at or near the skin.

These molecules, in combination with other drugs, could be used to develop dual anti-cholinesterase drugs to treat AD. The researchers plan to carry out further studies and synthesise novel ...